Insider Buying: Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases 18,226 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 18,226 shares of the stock in a transaction that occurred on Friday, January 10th. The stock was bought at an average price of $0.73 per share, with a total value of $13,304.98. Following the completion of the transaction, the chief executive officer now owns 14,966,204 shares of the company’s stock, valued at $10,925,328.92. The trade was a 0.12 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Retractable Technologies Trading Up 2.7 %

RVP stock traded up $0.02 during midday trading on Monday, reaching $0.76. The company’s stock had a trading volume of 18,091 shares, compared to its average volume of 143,135. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The stock has a fifty day simple moving average of $0.66 and a two-hundred day simple moving average of $0.84. Retractable Technologies, Inc. has a 1 year low of $0.56 and a 1 year high of $1.34. The firm has a market capitalization of $22.75 million, a price-to-earnings ratio of -1.41 and a beta of 1.94.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on Retractable Technologies in a research report on Monday, January 6th. They issued a “hold” rating for the company.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.